CPRX
Price
$20.55
Change
+$0.02 (+0.10%)
Updated
Oct 17 closing price
Capitalization
2.52B
18 days until earnings call
Intraday Buy/Sell Signals
NRIX
Price
$9.84
Change
-$0.19 (-1.89%)
Updated
Oct 17 closing price
Capitalization
756.53M
123 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CPRX vs NRIX

Header iconCPRX vs NRIX Comparison
Open Charts CPRX vs NRIXBanner chart's image
Catalyst Pharmaceuticals
Price$20.55
Change+$0.02 (+0.10%)
Volume$1.03M
Capitalization2.52B
Nurix Therapeutics
Price$9.84
Change-$0.19 (-1.89%)
Volume$603.74K
Capitalization756.53M
CPRX vs NRIX Comparison Chart in %
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPRX vs. NRIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (CPRX: $20.55 vs. NRIX: $9.84)
Brand notoriety: CPRX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 68% vs. NRIX: 59%
Market capitalization -- CPRX: $2.52B vs. NRIX: $756.53M
CPRX [@Biotechnology] is valued at $2.52B. NRIX’s [@Biotechnology] market capitalization is $756.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • CPRX’s TA Score: 5 bullish, 4 bearish.
  • NRIX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than NRIX.

Price Growth

CPRX (@Biotechnology) experienced а +0.93% price change this week, while NRIX (@Biotechnology) price change was +0.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CPRX is expected to report earnings on Nov 05, 2025.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.52B) has a higher market cap than NRIX($757M). CPRX YTD gains are higher at: -1.533 vs. NRIX (-47.771). CPRX has higher annual earnings (EBITDA): 281M vs. NRIX (-248.7M). CPRX has more cash in the bank: 653M vs. NRIX (429M). CPRX has less debt than NRIX: CPRX (2.99M) vs NRIX (56.5M). CPRX has higher revenues than NRIX: CPRX (558M) vs NRIX (83.7M).
CPRXNRIXCPRX / NRIX
Capitalization2.52B757M332%
EBITDA281M-248.7M-113%
Gain YTD-1.533-47.7713%
P/E Ratio12.45N/A-
Revenue558M83.7M667%
Total Cash653M429M152%
Total Debt2.99M56.5M5%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXNRIX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 24 days ago
68%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUXFX32.520.23
+0.71%
Auxier Focus Inv
DGFCX30.050.01
+0.03%
Davis Global C
ISJBX20.23N/A
N/A
Voya US Stock Index Port S
GLNBX21.31N/A
N/A
MFS Global New Discovery B
IGAIX45.23-0.13
-0.29%
American Funds Intl Gr and Inc F3

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.89%
KYMR - NRIX
65%
Loosely correlated
-1.04%
DNLI - NRIX
58%
Loosely correlated
-0.36%
IDYA - NRIX
58%
Loosely correlated
+5.67%
NUVL - NRIX
56%
Loosely correlated
+2.32%
XNCR - NRIX
56%
Loosely correlated
-1.20%
More